|
Volumn 17, Issue 7, 2009, Pages 847-850
|
Soluble transferrin receptor and depth of bone marrow suppression following high dose chemotherapy
|
Author keywords
Chemotherapy; Leukaemia therapy; Soluble transferrin receptor; Supportive care; Transfusion
|
Indexed keywords
AMSACRINE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
FLUDARABINE;
GRANULOCYTE COLONY STIMULATING FACTOR;
IDARUBICIN;
MELPHALAN;
SOLUBLE TRANSFERRIN RECEPTOR;
TRANSFERRIN RECEPTOR;
UNCLASSIFIED DRUG;
ACUTE GRANULOCYTIC LEUKEMIA;
ADULT;
ARTICLE;
BONE MARROW SUPPRESSION;
CANCER CHEMOTHERAPY;
CHRONIC MYELOID LEUKEMIA;
CLINICAL ARTICLE;
CONTINUOUS INFUSION;
DIAGNOSTIC VALUE;
DRUG DOSE REGIMEN;
DRUG MEGADOSE;
ERYTHROCYTE TRANSFUSION;
ERYTHROPOIESIS;
FEMALE;
HIGH RISK PATIENT;
HUMAN;
LEUKEMOGENESIS;
MALE;
MULTIPLE MYELOMA;
PREDICTION;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ERYTHROCYTE TRANSFUSION;
FEMALE;
HEMATOLOGIC NEOPLASMS;
HUMANS;
LEUKOPENIA;
MALE;
PILOT PROJECTS;
PREDICTIVE VALUE OF TESTS;
PROSPECTIVE STUDIES;
RECEPTORS, TRANSFERRIN;
SALVAGE THERAPY;
STEM CELL TRANSPLANTATION;
|
EID: 67349198873
PISSN: 09414355
EISSN: None
Source Type: Journal
DOI: 10.1007/s00520-009-0584-8 Document Type: Article |
Times cited : (6)
|
References (8)
|